Uncovering the Anti-Atherosclerotic Effect of Isoquercitrin via Microbiome Metabolic Modulation and Network Pharmacology
Journal of Agricultural and Food Chemistry · 17.09.2025 · 73 (37) · 23469-23485
DOI: 10.1021/acs.jafc.5c09903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 08.09.2025. Verfasst von Yan-Yan Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212003, China. Hauptthemen laut MEDLINE: Quercetin, Gastrointestinal Microbiome, Atherosclerosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Natural Science Research of Jiangsu Higher Education Institutions of China, Jiangsu University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Atherosclerosis (AS) is increasingly recognized as a disease influenced not only by lipid metabolism and inflammation but also by the gut microbiota and their bioactive metabolites. Isoquercitrin (ISO), a natural flavonoid with food-medicine homology, has shown promising antiatherosclerotic potential, yet its underlying mechanisms remain unclear. In this study, ISO administration significantly reduced plaque burden, improved lipid profiles, and restored gut microbial balance by enriching beneficial taxa, such as Lactobacillus, Dubosiella, and Eubacterium_R. These taxa are associated with beneficial microbial functions, including β-glucosidase activity, which facilitates ISO deglycosylation into cis-dihydroquercetin, 3,4-dihydroxyphenylpropionaldehyde (3,4-DHPPAL). ISO also reprogrammed tryptophan metabolism, promoting the production of indole derivatives (e.g., indolepyruvate, tryptophanol, and 5-methoxyindoleacetate) and suppressing the kynurenine pathway, thereby enhancing intestinal barrier integrity. Notably, network pharmacology and molecular docking identified HSP90β as a plausible host target of ISO and its metabolites (quercetin and cis-dihydroquercetin). Correlation analysis further linked the HSP90β expression to key enzymes in the tryptophan pathway, suggesting an integrated regulatory role. These findings suggest that ISO alleviates AS through a gut microbiota-tryptophan metabolism-HSP90β axis, offering new mechanistic insights into the therapeutic potential of natural compounds for cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212003, China.
- College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi 030000, China.
- Shanxi Key Laboratory of Experimental Animals and Animal Models for Human Diseases, Laboratory Animal Center, Shanxi Medical University, Taiyuan, Shanxi 030000, China.
ORCID-Profile: Yan-Yan Chen, Shi-Yuan Wen
Förderung
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Jiangsu University
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y. Y., Guo, J., Xue, S. L., Ding, L. L., Wei, B. Y., & Wen, S. Y. (2025). Uncovering the Anti-Atherosclerotic Effect of Isoquercitrin via Microbiome Metabolic Modulation and Network Pharmacology. Journal of Agricultural and Food Chemistry, 73(37), 23469-23485. https://doi.org/10.1021/acs.jafc.5c09903
Vancouver
Chen YY, Guo J, Xue SL, Ding LL, Wei BY, Wen SY. Uncovering the Anti-Atherosclerotic Effect of Isoquercitrin via Microbiome Metabolic Modulation and Network Pharmacology. Journal of Agricultural and Food Chemistry. 2025;73(37):23469-23485. doi:10.1021/acs.jafc.5c09903
BibTeX
@article{Chen2025,
author = {Chen, Yan-Yan and Guo, Jiao and Xue, Shu-Lan and Ding, Ling-Ling and Wei, Bing-Yan and Wen, Shi-Yuan},
title = {Uncovering the Anti-Atherosclerotic Effect of Isoquercitrin via Microbiome Metabolic Modulation and Network Pharmacology},
journal = {Journal of Agricultural and Food Chemistry},
year = {2025},
volume = {73},
number = {37},
pages = {23469--23485},
doi = {10.1021/acs.jafc.5c09903}
}
EUVIMED